Cargando…
Platelets and platelet-derived vesicles as an innovative cellular and subcellular platform for managing multiple sclerosis
INTRODUCTION: Multiple sclerosis (MS) is a progressive inflammatory autoimmune disease that involves young individuals. The drug delivery systems now are available for this disease have chronic and non-targeted effects on the patients. Because of the presence of BBB (blood-brain-barrier), their conc...
Autores principales: | Mehdi-Alamdarlou, Sanaz, Ahmadi, Fatemeh, Shahbazi, Mohammad-Ali, Azadi, Amir, Ashrafi, Hajar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078055/ https://www.ncbi.nlm.nih.gov/pubmed/37022526 http://dx.doi.org/10.1007/s11033-023-08322-7 |
Ejemplares similares
-
Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin
por: Mozafari, Negin, et al.
Publicado: (2020) -
A novel approach to the application of hexagonal mesoporous silica in solid-phase extraction of drugs
por: Farjadian, Fatemeh, et al.
Publicado: (2018) -
Evidence of platelet activation in multiple sclerosis
por: Sheremata, William A, et al.
Publicado: (2008) -
Platelets and Platelet‐Derived Extracellular Vesicles in Liver Physiology and Disease
por: Balaphas, Alexandre, et al.
Publicado: (2019) -
Subcellular platelet factor VIII antigen and von Willebrand factor
Publicado: (1975)